The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

Participants were given either the drug combination or the placebo. Researchers followed participants for two years to observe symptomatic recurrences. Secondary outcomes were renal scarring, failure ...

Millions of times a year, Americans seek urgent treatment for painful, embarrassing urinary tract infections. But while they ...

As if urinary tract infections weren’t bad enough, a new report claims that a popular over-the-counter drug used to treat UTI symptoms has been linked to cancer concerns. But this medication has not ...

Regulators have given a new antibiotic the green light to treat urinary tract infections (UTIs) for the first time in almost three decades. Gepotidacin, also known as Blujepa, can be used by women in ...

Gonorrhoea is resistant to nearly all antibiotics, but one commonly used for urinary tract infections (UTIs) may be able to treat drug-resistant cases. The sexually transmitted infection (STI) is ...

In a surveillance study of over 12 million bacteria, investigators at The George Washington University and Providence Hospital found E. coli antimicrobial resistance to ciprofloxacin, the most ...

A woman who has endured the pain of urinary tract infections (UTIs) all her adult life has welcomed the news that 99% of pharmacies in Wales will now able to treat the condition without a visit to the ...

Three lots of a drug designed to treat various urinary tract infections have been recalled because the white round tablets might have black spots from microbial contamination. The spotting of spots ...

Shares of Spero Therapeutics SPRO more than tripled in market value yesterday after a phase III study evaluating its investigational oral antibiotic for complicated urinary tract infections (cUTIs) ...